Verdezyne and Global Bioenergies share lessons learnt in progressing towards commercialisation on the EFIB 2015 innovation track

//Verdezyne and Global Bioenergies share lessons learnt in progressing towards commercialisation on the EFIB 2015 innovation track

Verdezyne and Global Bioenergies share lessons learnt in progressing towards commercialisation on the EFIB 2015 innovation track

There are prevailing challenges that renewable chemical companies are faced with when attempting to take their technology into full commercial production.

A key step in scale up is to conduct trials at a demonstration level fermentation facility, where large quantities of product can be made.

This will allow detailed design and engineering data to be collected and confirmation of the process and product at sufficient scale in order to de-risk production. Hence, one step closer to full commercial implementation…

Find out how you can scale up your industrial biotechnology towards commercialisation >>

Verdezyne and Global Bioenergies are two companies to experience the ups and downs of this process.

Their respective CEO and COO will be speaking during the EFIB innovation track to provide a unique perspective and guidance for biotech companies wanting to scale up their technology.

Book Your Ticket
By | July 9th, 2015|News from the web|0 Comments